All Pathways
DermatologyEmergency

Staphylococcal Scalded Skin Syndrome (SSSS)

Staphylococcal Scalded Skin Syndrome (SSSS): Suspected SSSS → Recognize Clinical Features → Differentiate from TEN → SSSS Confirmed → Identify S. aureus...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected SSSS

    Child with fever, tender erythema, superficial skin peeling

    1. Action

      Recognize Clinical Features

      Toxin-mediated superficial epidermal disease

      • Prodrome: Fever, irritability, skin tenderness
      • Erythema: Begins on face, spreads to trunk/extremities
      • Nikolsky sign positive: Gentle pressure causes skin to separate
      • Superficial blisters that rupture easily
      • MUCOUS MEMBRANES SPARED (key differentiator from TEN)
      • Usually in children <5 years, neonates
      1. Decision

        Differentiate from TEN

        Critical distinction - TEN is drug-induced with worse prognosis

        • SSSS: Mucous membranes SPARED
        • TEN: Mucous membranes ALWAYS involved (mouth, eyes, GU)
        • SSSS: Superficial (granular layer) cleavage
        • TEN: Full-thickness epidermal necrosis
        • SSSS: Usually children
        • TEN: Usually adults after medication
        • If uncertain: Skin biopsy distinguishes
        1. Action

          SSSS Confirmed

          Mucous membranes spared, clinical picture consistent

          1. Action

            Identify S. aureus Source

            Find and treat primary infection

            • Skin: Impetigo, wound infection
            • Conjunctivae
            • Nasopharynx (may be colonization site)
            • Umbilicus (neonates)
            • Blood cultures if systemically ill
            • Culture from site of infection (NOT blisters - usually sterile)
            1. Action

              Antistaphylococcal Antibiotics

              Start immediately - do not wait for cultures

              • MSSA: Nafcillin or Oxacillin 50-100 mg/kg/day IV divided q6h
              • Alternative: Cefazolin 50-100 mg/kg/day IV divided q8h
              • If MRSA suspected: Vancomycin 40-60 mg/kg/day IV divided q6h
              • Or Clindamycin 25-40 mg/kg/day IV divided q8h
              • Duration: IV until improving, then oral to complete 7-10 days
              • Oral step-down: Cephalexin, dicloxacillin, or clindamycin
              1. Action

                Supportive Care

                Similar to burn care but less aggressive

                • Fluid resuscitation (less than TEN - superficial involvement)
                • Temperature regulation - warm environment
                • Gentle handling of skin
                • Emollients - petroleum-based
                • Pain management
                • Electrolyte monitoring
                • Nutritional support
                1. Decision

                  Admission Decision

                  Based on extent and patient factors

                  1. Action

                    Inpatient Management

                    Most pediatric cases require admission

                    • Extensive disease (>10% BSA)
                    • Neonates
                    • Systemic toxicity
                    • Unable to take oral medications
                    • IV antibiotics initially
                    1. Outcome

                      Recovery

                      Excellent prognosis in children

                      • Re-epithelialization in 5-7 days
                      • Complete recovery typically 2 weeks
                      • NO scarring (superficial cleavage)
                      • Mortality 1-5% in children
                      • Recurrence rare
                    2. Warning

                      Complications

                      Rare but can be serious

                      • Sepsis (usually from primary infection site)
                      • Pneumonia
                      • Cellulitis
                      • Dehydration/electrolyte imbalance
                      • Adult SSSS: Mortality 50-60% (underlying comorbidities)
                      • ICU transfer if hemodynamically unstable
                  2. Action

                    Outpatient (Rare)

                    Only for mild, localized disease

                    • Very limited involvement
                    • Older child, reliable family
                    • Close follow-up in 24-48 hours
                    • Clear return precautions
              2. Action

                Wound Care

                Gentle, conservative approach

                • Leave blisters intact if possible
                • Non-adherent dressings (petrolatum gauze)
                • Avoid adhesive tape on affected skin
                • Silver sulfadiazine controversial (not usually needed)
                • Daily wound assessment
        2. Warning

          TEN Suspected

          Mucosal involvement present

          • Refer to SJS/TEN algorithm
          • Stop all suspect medications
          • Burn unit transfer
          • Much higher mortality

Guideline Source

StatPearls: Staphylococcal Scalded Skin Syndrome

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Must differentiate from TEN - different treatment and prognosis
  • Adult SSSS carries much higher mortality
  • MRSA prevalence may require empiric vancomycin
  • Source of S. aureus infection may be occult
  • Immunocompromised and renal failure patients at higher risk

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Staphylococcal Scalded Skin Syndrome (SSSS)?

The Staphylococcal Scalded Skin Syndrome (SSSS) is a emergency clinical algorithm for Dermatology. It provides a structured decision tree to guide clinical decision-making, based on StatPearls: Staphylococcal Scalded Skin Syndrome.

What guideline is the Staphylococcal Scalded Skin Syndrome (SSSS) based on?

This algorithm is based on StatPearls: Staphylococcal Scalded Skin Syndrome.

What are the limitations of the Staphylococcal Scalded Skin Syndrome (SSSS)?

Known limitations include: Must differentiate from TEN - different treatment and prognosis; Adult SSSS carries much higher mortality; MRSA prevalence may require empiric vancomycin; Source of S. aureus infection may be occult; Immunocompromised and renal failure patients at higher risk. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Staphylococcal Scalded Skin Syndrome (SSSS) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free